The use of granulocyte colony stimulating factor to promote wound healing in a neutropenic patient after head and neck surgery

Head and Neck

Volumn 21, Issue 2, 1999, Pages 172-175

  Cody II, D Thane ^a   Funk, Gerry F ^a   Wagner, David ^a   Gidley, Paul W ^a   Graham, Scott M ^a   Hoffman, Henry T ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Granulocyte colony stimulating factor; Neutropenia; Surgery; Wound healing

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE;

ADULT; ARTICLE; CANCER PATIENT; CASE REPORT; FELTY SYNDROME; FEMALE; FISTULA; HEAD AND NECK CANCER; HUMAN; LARYNGECTOMY; LARYNX CANCER; LEUKOCYTE COUNT; NEUTROPENIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; WOUND CLOSURE; WOUND HEALING;

CUTANEOUS FISTULA; FEMALE; FISTULA; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LARYNGECTOMY; MIDDLE AGED; NEUTROPENIA; PHARYNGEAL DISEASES; WOUND HEALING;

EID: 0033010945     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199903)21:2<172::AID-HED13>3.0.CO;2-1     Document Type: Article

References (38)

1. Violaris N, Bridger M. Prophylactic antibiotics and post laryngectomy pharyngocutaneous fistulae. J Laryngol Otol 1990;104:225-228.
2. Briant TD. Spontaneous pharyngeal fistula and wound infection following laryngectomy. Laryngoscope 1975;85: 829-834.
3. Dedo DD, Alonso WA, Ogura JH. Incidence, predisposing factors and outcome of pharyngocutaneous fistulas complicating head and neck cancer surgery. Ann Otol Rhinol Laryngol 1975;84:833-840.
4. Lavelle RJ, Maw AR. The aetiology of post-laryngectomy pharyngo-cutaneous fistulae. J Laryngol Otol 1972;86: 785-793.
5. Horgan EC, Dedo HH. Prevention of major and minor fistulae after laryngectomy. Laryngoscope 1979;89: 250-260.
6. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975;78:71-100.
7. Lennard TW, Shenton BK, Borzotta A, et al. The influence of surgical operations on components of the human immune system. Br J Surg 1985;72:771-776.
8. Christou NV, Meakins JL. Neutrophil function in surgical patients: two inhibitors of granulocyte chemotaxis associated with sepsis. J Surg Res 1979;26:355-364.
9. Duignan JP, Collins PB, Johnson AH, Bouchier-Hayes, D. The association of impaired neutrophil chemotaxis with postoperative surgical sepsis. Br J Surg 1986;73:238-240.
10. Jyung RW, Wu L, Pierce GF, Mustoe TA. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing. Surgery 1994;115:325-334.
11. Andresen J, Morstyn G. The potential role of G-CSF in the prevention of infections in non-neutropenic patients. Focus Growth Factors 1992;1:1-2.
12. Daifuku R, Andersen J, Morstyn G. Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases. J Antimicrob Chemother 1993;32:91-97.
13. Vadas MA, Lopez AF, Gamble JR, Elliot MJ. Role of colony-stimulating factors in leucocyte responses to inflammation and infection. Curr Opin Immunol 1991;3: 97-104.
14. Miller SH, Rudolph R. Healing in the irradiated wound. Clin Plast Surg 1990; 17:503-508.
15. Di Rosa M, Calignano A, Carnuccio R, Ialenti A, Sautebin L. Multiple control of inflammation by glucocorticoids. Agents Actions 1986;17:284-289.
16. Davidson SF, Brantley SK, Das SK. The effects of ultraviolet radiation on wound healing. Br J Plast Surg 1991; 44:210-214.
17. Ehrlichman RJ, Seckel BR, Bryan DJ, Moschella, CJ. Common complications of wound healing. Prevention and management. Surg Clin North Am 1991;71:1323-1351.
18. Hunt TK, Knighton DR, Thakral KK, Goodson WHD, Andrews WS. Studies on inflammation and wound healing: angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages. Surgery 1984;96:48-54.
19. Contran R, Kumar V, Robbins S. Pathological basis of disease. Philadelphia: Saunders; 1989.
20. Perrins DJD. The effect of hyperbaric oxygen on skin flaps. In: Grabb WC, Myers MB, editors. Skin flaps. Boston: Little, Brown; 1975.
21. LaVan FB, Hunt TK. Oxygen and wound healing. Clin Plast Surg 1990;17:463-472.
22. Young ME. Malnutrition and wound healing. Heart Lung 1988;17:60-67.
23. Haydock DA, Hill GL. Impaired wound healing in surgical patients with varying degrees of malnutrition. J Parenteral Enteral Nutr 1986;10:550-554.
24. Campbell DA, Corman LC, Williams RC, Jr. Splenectomy as treatment for nonhealing soft tissue defect after total knee arthroplasty in a patient with Felty's syndrome. J Rheumatol 1992;19:1126-1129.
25. Joseph G, Neustadt DH, Hamm J, Kellihan M, Hadley T. GM-CSF in the treatment of Felty syndrome. Am J Hematol 1991;37:55-56.
26. Wagner DR, Combe C Gresser U. GM-CSF and G-CSF in Felty's syndrome. Clin Invest 1993;71:168-171.
27. Tan N, Grisanti MW, Grisanti, JM. Oral methotrexate in the treatment of Felty's syndrome [Letter]. J Rheumatol 1993;20:599-601,
28. Kaprove RE. Felty's syndrome: case report and rationale for disease-suppressant immunosuppressive therapy. J Rheumatol 1981;8:791-796.
29. Dillon AM, Luthra HS, Conn DL, Ferguson RH. Parenteral gold therapy in the Felty syndrome. Experience with 20 patients. Medicine 1986;65:107-112.
30. Mant MJ, Akabutu JJ, Herbert FA. Lithium carbonate therapy in severe Felty's syndrome. Benefits, toxicity, and granulocyte function. Arch Intern Med 1986;146:277-280.
31. Wimer BM, Sloan MM. Remission of Felty's syndrome with long-term testosterone therapy. JAMA 1973;223: 671-673.
32. Lakhanpal S, Luthra HS. D-Penicillamine in Felty's syndrome. J Rheumatol 1985;12:703-706.
33. Wiesner KB, Shapiro RF, Bryan BL, Fuller C, Utsinger PD. Immunosuppressive therapy in Felty's syndrome [Letter]. N Engl J Med 1977;296:1172.
34. Boone AW, Evans SJ. Relapse of Felty's syndrome following splenectomy. J Maine Med Assoc 1973;64:266-267.
35. Clotet B, Argelagues E, Junca J, et al. Plasmapheresis in Felty's syndrome [Letter]. Scand J Rheumatol 1985;14: 438-439.
36. Coiffier, B. Cyclosporine in Felty's syndrome [Letter]. N Engl J Med 1986;314:184.
37. Besner GE, Glick PL, Karp MP, et al. Recombinant human granulocyte colony-stimulating factor promotes wound healing in a patient with congenital neutropenia. J Pediatr Surg 1992;27:288-291.
38. van Lindert AC, Symons EA, Damen BF, Heintz AP. Wound healing after radical vulvectomy and inguino-femoral lymphadenectomy: experience with granulocyte colony stimulating factor (filgrastim, r-metHuG-CSF). Eur J Obstet Gynecol Reproduct Biol 1995;62:217-219.